Sofosbuvir/Simeprevir Plus a Flat Dose of Ribavirin in Genotype 1 Elderly HCV Cirrhotic Patients

NCT02702739 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

270

Enrollment

OTHER

Sponsor class

Conditions

Liver Cirrhosis

Interventions

DRUG: Sofosbuvir 400mg/day/Simeprevir 150mg/day /Ribavirin 800mg/day for 12 weeks

Sponsor

Azienda Ospedaliera San Camillo Forlanini